Effectively Promoting Your Company As The Partner Of Choice Featured Speaker Of The Week Alex Scott Vice President, Business Development Eisai Corporation of North America Successfully Integrating Partner Companies After An Acquisition To Ensure Continued Productivity SMALL BIOTECHS INTERESTED IN ATTENDING BIONETWORK 2008 Please inquire about discounted rates at bionetwork@wbresearch.com

Key Benefits Of Attending BioNetwork 2008 Include:

• Network with senior decision makers from top pharmaceuticals and innovative biotechs
  
• Informal and relaxed atmosphere at BioNetwork’s engaging social networking events provides an excellent opportunity to build strong relationships with your targeted partners
  
• Therapeutic focus partnering primers maximizes your time away from the office, outlining partnering opportunities in specific therapeutic areas of interest
  
• The excellent ratio of pharmaceuticals to biotechs ensures that attendees can meet with the right partners for their company’s growth strategy

What’s New For 2008

• Focus On Specialty Pharma: With the traditional pharma paradigm being challenged by today’s economic realities, many executives are looking to incorporate the successes of specialty pharma into their own model. Join specialty pharma thought leaders as we evaluate how to join the best of both worlds into a plan of action for years to come.
• Card Swap Breakfasts: Start the day with an opportunity to meet some of your peers over breakfast. Each morning will foster discussions and spark ideas to be explored throughout the day’s sessions.
• Therapeutic Focus Partnering Primers: Enabling small biotechs to present their compounds/technologies available for partnering, these 10 minute presentations will provide innovative companies the opportunity to demonstrate their value in sessions focused on their therapeutic area of interest. Therapeutic areas to be presented include:
  
  
  • Metabolic Diseases
    
  • Central Nervous System
    
  • Inflammatory Diseases
    
  • Infectious Diseases

Networking Activities At BioNetwork 2008 Include:

• Card Swap Breakfasts on October 6-8
  
• Roundtables focused on specific therapeutic areas on October 6
  
• Roundtables addressing current business issues on October 7
  
• Receptions on October 6-7
  
• Golf Scramble on October 7
  
• Hands-on interactive workshops on October 8
  
• Private one-on-one meeting rooms throughout all 3 days!

Senior-Level Executives You Will Hear From Include:

	Markus Goebel Managing Director Novartis Venture Funds			Jag Dosanjh VP adult vaccines GlaxoSmithKline
	Jeff Southerton Executive Director, Pfizer Global R&D, WW Business Development Pfizer			Michael Leonetti Head of Healthcare Partnerships Boehringer Ingelheim
	Mark Barbato Vice President Alliance Management Eli Lilly and Company			Shabnam Kazmi Vice President Business Development Sanofi-Aventis
	Jim Schaeffer Executive Director, Licensing And External Research Merck Research Laboratories, West Coast Merck			Gayle Kirkpatrick Divisional Vice President, Scientific Assessment & Licensing Global Pharmaceutical Licensing & New Business Development Abbott